glp-1 alzheimer's Popular obesity drug fails in hotly anticipated trials | Science GLP-1a: Going beyond Traditional Use

In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 percent of their body weight.

Meals heat in about 90 seconds in heat-sealed trays and arrive packaged with quality ingredients and practical sustainability in mind

A new case series presents a unique paradox where GLP-1 RA therapy improved quality of life and resolved diarrhea in two women with

License this stock photo and more images of Stock photo Diagram of how GLP-1 glucagon-like peptide drugs promote weight loss

Supergut CEO Marc Washington on riding the Ozempic wave, the importance of prebiotic fibre, boosting GLP-1, and formulating vegan products.

Maintenance support following prescription GLP-1 therapy